Evidence map›Paper›PMID 42230354›Full record

ArticleWorld journal of urology2026

Applying classification of intraoperative adverse events (ClassIntra) to robot-assisted radical prostatectomy to predict the risk of postoperative adverse events.

Shinya Somiya, Ryoichi Saito, Toru Kanno, Masashi Kubota, Takayuki Sumiyoshi, Masaaki Imamura, Kyohei Sugiyama, Masahiro Tamaki, Tomohiro Fukui, Hiroshi Iwamura and 10 more

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Shinya SomiyaDepartment of Urology, Kyoto University Graduate School of Medicine, 54 Shogoinkawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Ryoichi SaitoDepartment of Urology, Kyoto University Graduate School of Medicine, 54 Shogoinkawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Toru KannoDepartment of Urology, Kyoto University Graduate School of Medicine, 54 Shogoinkawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Masashi KubotaDepartment of Urology, Kyoto University Graduate School of Medicine, 54 Shogoinkawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Takayuki SumiyoshiDepartment of Urology, Kyoto University Graduate School of Medicine, 54 Shogoinkawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Masaaki ImamuraDepartment of Urology, Shizuoka General Hospital, Shizuoka, Japan.
Kyohei SugiyamaDepartment of Urology, Kurashiki Central Hospital, Okayama, Japan.
Masahiro TamakiDepartment of Urology, Japanese Red Cross Wakayama Medical Center, Wakayama, Japan.
Tomohiro FukuiDepartment of Urology, Toyooka Hospital, Hyogo, Japan.
Hiroshi IwamuraDepartment of Urology, Himeji Medical Center, Hyogo, Japan.
Ryosuke SuzukiDepartment of Urology, Numazu City Hospital, Shizuoka, Japan.
Kimihiro ShimataniDepartment of Urology, Hyogo Medical University, Hyogo, Japan.
Yuya SekineDepartment of Urology, Akita University Graduate School of Medicine, Akita, Japan.
Ryoma KurahashiFaculty of Life Sciences, Department of Urology, Kumamoto University, Kumamoto, Japan.
Atsuro SawadaDepartment of Urology, Miyazaki University, Miyazaki, Japan.
Hiromitsu NegoroDepartment of Urology, University of Tsukuba, Ibaraki, Japan.
Shusuke AkamatsuDepartment of Urology, Nagoya University, Aichi, Japan.
Takayuki GotoDepartment of Urology, Kyoto University Graduate School of Medicine, 54 Shogoinkawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan. goto@kuhp.kyoto-u.ac.jp.
Takashi KobayashiDepartment of Urology, Kyoto University Graduate School of Medicine, 54 Shogoinkawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan. selecao@kuhp.kyoto-u.ac.jp.
Daimonji Clinical Application Database (Dai-CAD) study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo investigate intraoperative adverse events (IAEs) during robot-assisted radical prostatectomy using classification of intraoperative adverse events (ClassIntra) and their association with postoperative adverse events. PATIENTS AND

methodsThis was a retrospective population-based cohort identified from an approved common database (Dai-CAD) for robot-assisted radical prostatectomy for prostate cancer at 25 Japanese institutions between 2011 and 2023. IAEs were graded according to ClassIntra. The association between IAEs and postoperative adverse events was examined using multivariate logistic regression analysis.

resultOf the 8193 patients, 9 were excluded due to concurrent colon or rectal surgery concurrently (n = 6) and salvage surgery (n = 3), and the remaining 8184 patients were included in this study. Of the 8184 patients, 88 experienced ClassIntra grade ≥  2 IAEs. Among them, 50 patients (57%) experienced grade 2 IAEs, 32 (36%) experienced grade 3 IAEs, six patients (6.8%) experienced grade 4 IAEs, and no patients experienced grade 5 IAEs. Multivariate analysis revealed that ClassIntra grade   ≥   2 IAEs were independent risk factors for Clavien-Dindo grade ≥ 2 postoperative adverse events (odds ratio [OR] 2.62, 95% confidence interval [95%CI] 1.44-4.75, p = 0.002). Furthermore, ClassIntra grade   ≥  3 IAEs were independent risk factors for Clavien-Dindo grade  ≥  2 (OR 5.23, 95%CI 2.43-11.2, p < 0.001) or ≥ 3 postoperative adverse events (OR 4.92, 95%CI 1.49-16.3, p = 0.009).

conclusionEvaluating IAEs according to ClassIntra is associated with postoperative adverse events and may support postoperative risk assessment according to the Clavien-Dindo classification.

Indexed as

Intraoperative ComplicationsPostoperative ComplicationsProstatectomyProstatic NeoplasmsRobotic Surgical ProceduresAgedHumansMaleMiddle AgedRetrospective StudiesRisk AssessmentRisk FactorsClassIntraComplicationsIntraoperative adverse eventsMinimally invasive surgeryRobot assisted radical prostatectomy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.